These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 28341748)

  • 21. A Novel MicroRNA Signature for Cholestatic Drugs in Human Hepatocytes and Its Translation into Novel Circulating Biomarkers for Drug-Induced Liver Injury Patients.
    López-Riera M; Conde I; Castell JV; Jover R
    Toxicol Sci; 2020 Feb; 173(2):229-243. PubMed ID: 31198949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specificity of transaminase activities in the prediction of drug-induced hepatotoxicity.
    Kobayashi A; Suzuki Y; Sugai S
    J Toxicol Sci; 2020; 45(9):515-537. PubMed ID: 32879252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital.
    Antoine DJ; Dear JW; Lewis PS; Platt V; Coyle J; Masson M; Thanacoody RH; Gray AJ; Webb DJ; Moggs JG; Bateman DN; Goldring CE; Park BK
    Hepatology; 2013 Aug; 58(2):777-87. PubMed ID: 23390034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a cell-based assay system considering drug metabolism and immune- and inflammatory-related factors for the risk assessment of drug-induced liver injury.
    Yano A; Oda S; Fukami T; Nakajima M; Yokoi T
    Toxicol Lett; 2014 Jul; 228(1):13-24. PubMed ID: 24747151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current challenges and controversies in drug-induced liver injury.
    Corsini A; Ganey P; Ju C; Kaplowitz N; Pessayre D; Roth R; Watkins PB; Albassam M; Liu B; Stancic S; Suter L; Bortolini M
    Drug Saf; 2012 Dec; 35(12):1099-117. PubMed ID: 23137150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial.
    Asgarshirazi M; Shariat M; Sheikh M
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):296-302. PubMed ID: 28603098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.
    Fontana RJ; Hayashi PH; Barnhart H; Kleiner DE; Reddy KR; Chalasani N; Lee WM; Stolz A; Phillips T; Serrano J; Watkins PB;
    Am J Gastroenterol; 2015 Oct; 110(10):1450-9. PubMed ID: 26346867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
    Hussaini SH; Farrington EA
    Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of in vitro combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury.
    Goda K; Takahashi T; Kobayashi A; Shoda T; Kuno H; Sugai S
    J Toxicol Sci; 2016; 41(5):605-15. PubMed ID: 27665770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of Preclinical Liver and Skeletal Muscle Biomarkers Following Clofibrate Administration in Wistar Rats.
    Maliver P; Festag M; Bennecke M; Christen F; Bánfai B; Lenz B; Winter M
    Toxicol Pathol; 2017 Jun; 45(4):506-525. PubMed ID: 28485676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenomics of drug-induced liver injury (DILI): Molecular biology to clinical applications.
    Kaliyaperumal K; Grove JI; Delahay RM; Griffiths WJH; Duckworth A; Aithal GP
    J Hepatol; 2018 Oct; 69(4):948-957. PubMed ID: 29792895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human leukocyte antigen genetic risk factors of drug-induced liver toxicology.
    Grove JI; Aithal GP
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):395-409. PubMed ID: 25491399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Setting Clinical Exposure Levels of Concern for Drug-Induced Liver Injury (DILI) Using Mechanistic in vitro Assays.
    Shah F; Leung L; Barton HA; Will Y; Rodrigues AD; Greene N; Aleo MD
    Toxicol Sci; 2015 Oct; 147(2):500-14. PubMed ID: 26206150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of urinary microRNA profiles in rats that may diagnose hepatotoxicity.
    Yang X; Greenhaw J; Shi Q; Su Z; Qian F; Davis K; Mendrick DL; Salminen WF
    Toxicol Sci; 2012 Feb; 125(2):335-44. PubMed ID: 22112502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is toxicogenomics a more reliable and sensitive biomarker than conventional indicators from rats to predict drug-induced liver injury in humans?
    Zhang M; Chen M; Tong W
    Chem Res Toxicol; 2012 Jan; 25(1):122-9. PubMed ID: 22122743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-122 and other microRNAs as potential circulating biomarkers of drug-induced liver injury.
    Howell LS; Ireland L; Park BK; Goldring CE
    Expert Rev Mol Diagn; 2018 Jan; 18(1):47-54. PubMed ID: 29235390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-course changes in the expression levels of miR-122, -155, and -21 as markers of liver cell damage, inflammation, and regeneration in acetaminophen-induced liver injury in rats.
    Park HK; Jo W; Choi HJ; Jang S; Ryu JE; Lee HJ; Lee H; Kim H; Yu ES; Son WC
    J Vet Sci; 2016 Mar; 17(1):45-51. PubMed ID: 27051339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in Bile Acid Concentrations after Administration of Ketoconazole or Rifampicin to Chimeric Mice with Humanized Liver.
    Sanoh S; Tamura Y; Fujino C; Sugahara G; Yoshizane Y; Yanagi A; Kisoh K; Ishida Y; Tateno C; Ohta S; Kotake Y
    Biol Pharm Bull; 2019; 42(8):1366-1375. PubMed ID: 31366871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro assessment of farnesoid X receptor antagonism to predict drug-induced liver injury risk.
    Norona LM; Fullerton A; Lawson C; Leung L; Brumm J; Kiyota T; Maher J; Khojasteh C; Proctor WR
    Arch Toxicol; 2020 Sep; 94(9):3185-3200. PubMed ID: 32583097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-induced liver injury: results from the hospital-based Berlin Case-Control Surveillance Study.
    Douros A; Bronder E; Andersohn F; Klimpel A; Thomae M; Sarganas G; Kreutz R; Garbe E
    Br J Clin Pharmacol; 2015 Jun; 79(6):988-99. PubMed ID: 25444550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.